TY - JOUR
T1 - Employing patient-reported outcome (PRO) measures to support newly diagnosed patients with melanoma
T2 - feasibility and acceptability of a holistic needs assessment intervention
AU - Kotronoulas, Grigorios
AU - Connaghan, John
AU - Grenfell, Jean
AU - Gupta, Girish
AU - Smith, Leigh
AU - Simpson, Mhairi
AU - Maguire, Roma
N1 - Copyright © 2017 Elsevier Ltd. All rights reserved.
PY - 2017/12/31
Y1 - 2017/12/31
N2 - PURPOSE:
Living with a melanoma diagnosis can be challenging. We aimed to assess the
feasibility, acceptability, and perceived value of a nurse-led intervention
that utilised patient-reported outcome (PRO) measures to identify and address
the supportive care needs of newly diagnosed patients with Stage I/II melanoma
over the first 4 months post-diagnosis.METHODS: We
conducted an exploratory, repeated-measures, single-arm, feasibility trial. One
baseline (4 weeks post-diagnosis; T1) and one follow-up intervention session (4
weeks after wide local excision; T3) took place, two months apart. Patient
survey data were collected monthly, at four assessment points (T1-T4), followed
by exit interviews.RESULTS: A
recruitment rate of 55% (10/18) was achieved. The skin cancer nurse specialist
(CNS) performed 19 in-clinic patient assessments within 6 months. One patient
missed their follow-up intervention session (90% retention rate). Three
participants (30%) were lost to follow-up at T4. Patients endorsed the
standardised use of easy-to-use PRO measures as a means to help them shortlist,
report and prioritise their needs. The CNS viewed the intervention as a highly
structured activity that allowed tailoring support priority needs. A sizeable
reduction in information needs was found from T1 to T4 (Standardised Response
Mean [SRM] change = -0.99; p < 0.05). From T1 to T2, significant reductions
in psychological (SRM change = -1.18; p < 0.001), practical (SRM change =
-0.67; p < 0.05) and sexuality needs (SRM change = -0.78; p < 0.05) were
observed.CONCLUSIONS:
The intervention appears to be feasible in clinical practice and acceptable to
both patients with newly diagnosed melanoma and clinicians. Future research is
warranted to test its effectiveness against standard care.
AB - PURPOSE:
Living with a melanoma diagnosis can be challenging. We aimed to assess the
feasibility, acceptability, and perceived value of a nurse-led intervention
that utilised patient-reported outcome (PRO) measures to identify and address
the supportive care needs of newly diagnosed patients with Stage I/II melanoma
over the first 4 months post-diagnosis.METHODS: We
conducted an exploratory, repeated-measures, single-arm, feasibility trial. One
baseline (4 weeks post-diagnosis; T1) and one follow-up intervention session (4
weeks after wide local excision; T3) took place, two months apart. Patient
survey data were collected monthly, at four assessment points (T1-T4), followed
by exit interviews.RESULTS: A
recruitment rate of 55% (10/18) was achieved. The skin cancer nurse specialist
(CNS) performed 19 in-clinic patient assessments within 6 months. One patient
missed their follow-up intervention session (90% retention rate). Three
participants (30%) were lost to follow-up at T4. Patients endorsed the
standardised use of easy-to-use PRO measures as a means to help them shortlist,
report and prioritise their needs. The CNS viewed the intervention as a highly
structured activity that allowed tailoring support priority needs. A sizeable
reduction in information needs was found from T1 to T4 (Standardised Response
Mean [SRM] change = -0.99; p < 0.05). From T1 to T2, significant reductions
in psychological (SRM change = -1.18; p < 0.001), practical (SRM change =
-0.67; p < 0.05) and sexuality needs (SRM change = -0.78; p < 0.05) were
observed.CONCLUSIONS:
The intervention appears to be feasible in clinical practice and acceptable to
both patients with newly diagnosed melanoma and clinicians. Future research is
warranted to test its effectiveness against standard care.
KW - melanoma
KW - supportive care needs
KW - patient-reported outcome measures
KW - cancer nurse specialist
KW - feasibility
KW - acceptability
UR - http://www.scopus.com/inward/record.url?scp=85046861184&partnerID=8YFLogxK
U2 - 10.1016/j.ejon.2017.10.002
DO - 10.1016/j.ejon.2017.10.002
M3 - Article
C2 - 29173828
SN - 1462-3889
VL - 31
SP - 59
EP - 68
JO - European Journal of Oncology Nursing
JF - European Journal of Oncology Nursing
ER -